BioNTech SE (NASDAQ:BNTX) shares closed up 9% to $104.44 following its release of financial results for the last quarter. In its report it noted that more than 200 million doses of its COVID-19 vaccine, BNT162b2, have been supplied as of March 23, 2021, with signed orders for 1.4 billion doses to date for delivery in 2021, equating to revenues of €9.8 billion. The company recorded COVID-19 vaccine revenues of €270.5 million for the 2020.
Seelos Therapeutics, Inc. (NASDAQ:SEEL) shares closed up 16% to $4.96. Analysts at B.Riley initiated coverage of the stock with a Buy rating and a price target of $15.00.
Moleculin Biotech, Inc. (NASDAQ:MBRX) shares closed up 15% to $4.25 with investors reacting to news that the FDA issued Fast Track Designation (FTD) for its drug, Annamycin, for the treatment of soft tissue sarcoma (STS) lung metastases. FTD is designed to expedite development of pharmaceutical products which demonstrate the potential to address unmet medical needs in serious or life-threatening conditions.
Vaxcyte, Inc. (NASDAQ:PCVX) shares closed down 18% to $18.66 following an update in its earnings report after hours on Monday that its Investigational New Drug (IND) application for VAX-24, its 24-valent pneumococcal conjugate vaccine (PCV), has been delayed to the first half of 2022.
ProQR Therapeutics N.V. (NASDAQ:PRQR) announced after hours that it intends to sell its ordinary shares in an underwritten public offering. Shares are trading down 3% after hours to $6.90 after closing normal hours down 9%.
9 Meters Biopharma, Inc. (NASDAQ:NMTR) also announced that it has commenced a proposed underwritten public offering of shares of its common stock. Shares are trading down 12% to $1.20 after hours.
-
Major price movers (stocks priced > $1.00, volume > 50k listed on NASDAQ/NYSE):
Refer to the BioPharmCatalyst Biotech Stocks page for Top 10 Gainers/Losers/Unusual Volume:
ADVANCERS:
Savara Inc. (SVRA): $1.94; +22%.
Cyclo Therapeutics, Inc. (CYTH): $8.37; +18%.
Novan, Inc. (NOVN): $1.60; +17%.
Monopar Therapeutics Inc. (MNPR): $6.70; +16%.
AbCellera Biologics Inc. (ABCL): $26.68; +15%.
DECLINERS:
Wave Life Sciences Ltd. (WVE): $5.96; -16%.
Applied Molecular Transport Inc. (AMTI): $42.01; -14%.
Edgewise Therapeutics, Inc. (EWTX): $31.22; -13%.
Design Therapeutics, Inc. (DSGN): $29.52; -13%.
Osmotica Pharmaceuticals plc (OSMT): $3.51; -12%.
Pipeline updates below: